Landscapes / Targets
Syk
5 drugs act on Syk, in 6 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Fostamatinibnot checked |
Tyrosine kinase inhibitor |
Approved | — | ||
| How it works | Blocks a kinase | ||||
| Also tested for | Warm Antibody Autoimmune Hemolytic Anemia | ||||
| Open drug page | |||||
— |
Phase 3 | Mar 2027Phase 3 trial completes | |||
| Next date | Mar 2027 · Phase 3 trial completes | ||||
| Also tested for | Primary Immune Thrombocytopenia | ||||
| Open drug page | |||||
— |
Phase 2/3 | — | |||
| Also tested for | Warm Antibody Autoimmune Hemolytic Anemia | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Phase 1/2 | Nov 2026soonPhase 1/2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | Nov 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Leukemia, Myeloid, Acute, Refractory AML and 3 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2026Phase 1 trial completes | |||
| Next date | 31 Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Bioequivalence Study in Healthy Subjects, Immune Thrombocytopenia (ITP) and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 5 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026